The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Amiodarone-Global Market Insights and Sales Trends 2024
Synopsis
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
The global Amiodarone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Amiodarone in various end use industries. The expanding demands from the Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation and Others, are propelling Amiodarone market. Tablet Amiodarone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule Amiodarone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Amiodarone market, driven by demand from China, the second largest economy with some signs of stabilising, the Amiodarone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amiodarone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amiodarone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amiodarone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amiodarone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amiodarone covered in this report include Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals(Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals and North China Pharmaceutical Company, etc.
The global Amiodarone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Global Amiodarone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amiodarone market, Segment by Type:
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Global Amiodarone market, by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
The global Amiodarone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Amiodarone in various end use industries. The expanding demands from the Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation and Others, are propelling Amiodarone market. Tablet Amiodarone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsule Amiodarone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Amiodarone market, driven by demand from China, the second largest economy with some signs of stabilising, the Amiodarone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amiodarone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amiodarone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amiodarone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amiodarone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amiodarone covered in this report include Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals(Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals and North China Pharmaceutical Company, etc.
The global Amiodarone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Global Amiodarone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amiodarone market, Segment by Type:
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Global Amiodarone market, by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Amiodarone Market Overview
1.1 Amiodarone Product Overview
1.2 Amiodarone Market Segment by Type
1.2.1 Tablet Amiodarone
1.2.2 Capsule Amiodarone
1.2.3 Injection Amiodarone
1.3 Global Amiodarone Market Size by Type
1.3.1 Global Amiodarone Market Size Overview by Type (2018-2029)
1.3.2 Global Amiodarone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Amiodarone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Amiodarone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Amiodarone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Amiodarone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Amiodarone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Amiodarone Sales Breakdown by Type (2018-2023)
2 Global Amiodarone Market Competition by Company
2.1 Global Top Players by Amiodarone Sales (2018-2023)
2.2 Global Top Players by Amiodarone Revenue (2018-2023)
2.3 Global Top Players by Amiodarone Price (2018-2023)
2.4 Global Top Manufacturers Amiodarone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Amiodarone Market Competitive Situation and Trends
2.5.1 Amiodarone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Amiodarone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amiodarone as of 2022)
2.7 Date of Key Manufacturers Enter into Amiodarone Market
2.8 Key Manufacturers Amiodarone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Amiodarone Status and Outlook by Region
3.1 Global Amiodarone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Amiodarone Historic Market Size by Region
3.2.1 Global Amiodarone Sales in Volume by Region (2018-2023)
3.2.2 Global Amiodarone Sales in Value by Region (2018-2023)
3.2.3 Global Amiodarone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Amiodarone Forecasted Market Size by Region
3.3.1 Global Amiodarone Sales in Volume by Region (2024-2029)
3.3.2 Global Amiodarone Sales in Value by Region (2024-2029)
3.3.3 Global Amiodarone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Amiodarone by Application
4.1 Amiodarone Market Segment by Application
4.1.1 Cardiac Arrest
4.1.2 Ventricular Tachycardia
4.1.3 Atrial Fibrillation
4.1.4 Others
4.2 Global Amiodarone Market Size by Application
4.2.1 Global Amiodarone Market Size Overview by Application (2018-2029)
4.2.2 Global Amiodarone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Amiodarone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Amiodarone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Amiodarone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Amiodarone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Amiodarone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Amiodarone Sales Breakdown by Application (2018-2023)
5 North America Amiodarone by Country
5.1 North America Amiodarone Historic Market Size by Country
5.1.1 North America Amiodarone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Amiodarone Sales in Volume by Country (2018-2023)
5.1.3 North America Amiodarone Sales in Value by Country (2018-2023)
5.2 North America Amiodarone Forecasted Market Size by Country
5.2.1 North America Amiodarone Sales in Volume by Country (2024-2029)
5.2.2 North America Amiodarone Sales in Value by Country (2024-2029)
6 Europe Amiodarone by Country
6.1 Europe Amiodarone Historic Market Size by Country
6.1.1 Europe Amiodarone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Amiodarone Sales in Volume by Country (2018-2023)
6.1.3 Europe Amiodarone Sales in Value by Country (2018-2023)
6.2 Europe Amiodarone Forecasted Market Size by Country
6.2.1 Europe Amiodarone Sales in Volume by Country (2024-2029)
6.2.2 Europe Amiodarone Sales in Value by Country (2024-2029)
7 Asia-Pacific Amiodarone by Region
7.1 Asia-Pacific Amiodarone Historic Market Size by Region
7.1.1 Asia-Pacific Amiodarone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Amiodarone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Amiodarone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Amiodarone Forecasted Market Size by Region
7.2.1 Asia-Pacific Amiodarone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Amiodarone Sales in Value by Region (2024-2029)
8 Latin America Amiodarone by Country
8.1 Latin America Amiodarone Historic Market Size by Country
8.1.1 Latin America Amiodarone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Amiodarone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Amiodarone Sales in Value by Country (2018-2023)
8.2 Latin America Amiodarone Forecasted Market Size by Country
8.2.1 Latin America Amiodarone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Amiodarone Sales in Value by Country (2024-2029)
9 Middle East and Africa Amiodarone by Country
9.1 Middle East and Africa Amiodarone Historic Market Size by Country
9.1.1 Middle East and Africa Amiodarone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Amiodarone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Amiodarone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Amiodarone Forecasted Market Size by Country
9.2.1 Middle East and Africa Amiodarone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Amiodarone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Amiodarone Products Offered
10.1.5 Sanofi Recent Development
10.2 Sawai Pharmaceutical
10.2.1 Sawai Pharmaceutical Company Information
10.2.2 Sawai Pharmaceutical Introduction and Business Overview
10.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sawai Pharmaceutical Amiodarone Products Offered
10.2.5 Sawai Pharmaceutical Recent Development
10.3 Wyeth Pharmaceuticals(Pfizer)
10.3.1 Wyeth Pharmaceuticals(Pfizer) Company Information
10.3.2 Wyeth Pharmaceuticals(Pfizer) Introduction and Business Overview
10.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Wyeth Pharmaceuticals(Pfizer) Amiodarone Products Offered
10.3.5 Wyeth Pharmaceuticals(Pfizer) Recent Development
10.4 Mylan Pharmaceuticals
10.4.1 Mylan Pharmaceuticals Company Information
10.4.2 Mylan Pharmaceuticals Introduction and Business Overview
10.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Pharmaceuticals Amiodarone Products Offered
10.4.5 Mylan Pharmaceuticals Recent Development
10.5 Arrow Pharma Pty Ltd
10.5.1 Arrow Pharma Pty Ltd Company Information
10.5.2 Arrow Pharma Pty Ltd Introduction and Business Overview
10.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Arrow Pharma Pty Ltd Amiodarone Products Offered
10.5.5 Arrow Pharma Pty Ltd Recent Development
10.6 Roemmers
10.6.1 Roemmers Company Information
10.6.2 Roemmers Introduction and Business Overview
10.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Roemmers Amiodarone Products Offered
10.6.5 Roemmers Recent Development
10.7 Cipla Pharmaceutical
10.7.1 Cipla Pharmaceutical Company Information
10.7.2 Cipla Pharmaceutical Introduction and Business Overview
10.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cipla Pharmaceutical Amiodarone Products Offered
10.7.5 Cipla Pharmaceutical Recent Development
10.8 Shanghai Pharmaceuticals
10.8.1 Shanghai Pharmaceuticals Company Information
10.8.2 Shanghai Pharmaceuticals Introduction and Business Overview
10.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Shanghai Pharmaceuticals Amiodarone Products Offered
10.8.5 Shanghai Pharmaceuticals Recent Development
10.9 North China Pharmaceutical Company
10.9.1 North China Pharmaceutical Company Company Information
10.9.2 North China Pharmaceutical Company Introduction and Business Overview
10.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 North China Pharmaceutical Company Amiodarone Products Offered
10.9.5 North China Pharmaceutical Company Recent Development
10.10 Harbin Pharmaceutical Group
10.10.1 Harbin Pharmaceutical Group Company Information
10.10.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Harbin Pharmaceutical Group Amiodarone Products Offered
10.10.5 Harbin Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Amiodarone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Amiodarone Industrial Chain Analysis
11.4 Amiodarone Market Dynamics
11.4.1 Amiodarone Industry Trends
11.4.2 Amiodarone Market Drivers
11.4.3 Amiodarone Market Challenges
11.4.4 Amiodarone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Amiodarone Distributors
12.3 Amiodarone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
